31 July 2002

According to the Swedish Medical Products Agency, the official health certification body in Sweden, "Dar Al Dawa Development and Investment Co. fulfills the demands according to the EU-GMP and is therefore accepted as a pharmaceutical supplier of solid dosage forms".

The Managing Director of Dar Al Dawa, Dr. Mohammad Fityani, affirmed that the company is currently standing on the threshold of a new era, an era that will open new non-traditional markets and will return additional revenues and enhance profits. Dr. Fityani added that Dar Al Dawa is also working on registering several products in different European markets, and we hope to finalize the registration requirements for two products during the year 2003.

Dr. Fityani thanked all the employees for their significant achievement, and stated that the EU-GMP certificate is the tangible result of their continuous efforts and initiative to upgrade the facilities and systems of the company to the highest standards.

-Ends-

© Press Release 2005